President of R&D, Therapeutics
Mon, Apr 14, 2025
Apr 14
8,378 shares @ $25.11
Decreased holdings by -25.90%
8th largest trade (out of 68)
Positive 90D History
Trade made by an officer
10b5-1 scheduled trade
100% win rate · +29.9% median edge vs SPY (22 trades, 90-day)
Price 28% above 200-day moving average
Small Cap stock — insider trades carry more weight